January’s performance so far has been a rollercoaster ride filled with ups and downs. Last week’s turnaround has spurred investor...
Read moreDetailsClinical stage biopharma small-cap, Harpoon Therapeutics has entered the spotlight with pharma giant, Merck agreeing to acquire the company for...
Read moreDetailsDecember's Consumer Price Index (CPI) data is in, and it brought a mixed bag of news for investors and consumers...
Read moreDetailsThe first-ever U.S. spot bitcoin ETFs began trading on Thursday, January 11th, 2024, marking a long-awaited milestone for the cryptocurrency...
Read moreDetailsAfter a week of mixed signals from policymakers and earnings reports, investors were eager to embrace a tech-fueled rally on...
Read moreDetailsAxonics witnessed its stock soar following the announcement of its acquisition by Boston Scientific in a staggering $3.7 billion deal.
Read moreDetailsFriday’s trading session reflected the current market sentiment: a swing of emotions with murmurs of hope amidst lingering anxieties.
Read moreDetailsWhile traditional blue-chips navigate choppy waters, the meme stock hype seems far from over. GameStop, AMC, and other internet-famous names...
Read moreDetailsStocks were higher this Monday afternoon as the stock market bounced back from Friday's sell-off. While the S&P 500 and...
Read moreDetailsU.S. stocks traded sideways on Wednesday, January 10, lacking a clear direction as investors eagerly await key inflation data and...
Read moreDetailsThese Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.
CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE
To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.
If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.
© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.